I’m bothered with the ‘you smoke cigarettes and you smoke weed, if cigarettes cause cancer weed does’ anti-science here. There are studies suggest the opposite, that smoking weed can reduce some forms of cancer. I’m not aware of a single study demonstrating that pot smokers who don’t ALSO smoke tobacco have any increased cancer rate.
Marijuana use and cancer incidence (California, United States). Sidney
S, Quesenberry CP Jr, Friedman GD, Tekawa IS. Source Division of
Research, Kaiser Permanente Medical Care Program, Oakland, California
94611-5714, USA. Abstract The purpose of this retrospective cohort
study was to examine the relationship of marijuana use to cancer
incidence. The study population consisted of 64,855 examinees in the
Kaiser Permanente multiphasic health checkup in San Francisco and
Oakland (California, United States), between 1979-85, aged 15 to 49
years, who completed self-administered questionnaires about smoking
habits, including marijuana use. Follow-up for cancer incidence was
conducted through 1993 (mean length 8.6 years). Compared with
nonusers/experimenters (lifetime use of less than seven times), ever-
and current use of marijuana were not associated with increased risk
of cancer of all sites (relative risk [RR] = 0.9, 95 percent
confidence interval [CI] = 0.7-12 for ever-use in men; RR = 1.0, CI =
0.8-1.1 in women) in analyses adjusted for sociodemographic factors,
cigarette smoking, and alcohol use. Marijuana use also was not
associated with tobacco-related cancers or with cancer of the
following sites: colorectal, lung, melanoma, prostate, breast, cervix.
Among nonsmokers of tobacco cigarettes, ever having used marijuana was
associated with increased risk of prostate cancer (RR = 3.1, CI =
1.0-9.5) and nearly significantly increased risk of cervical cancer
(RR = 1.4, CI = 1.0-2.1). We conclude that, in this relatively young
study cohort, marijuana use and cancer were not associated in overall
analyses, but that associations in nonsmokers of tobacco cigarettes
suggested that marijuana use might affect certain site-specific cancer
risks.
Cannabinoids in the treatment of cancer Amy Alexandera, Paul F.
Smitha and Rhonda J. Rosengren , a, Abstract Cannabinoids, the
active components of the hemp plant Cannabis sativa, along with their
endogenous counterparts and synthetic derivatives, have elicited
anti-cancer effects in many different in vitro and in vivo models of
cancer. While the various cannabinoids have been examined in a variety
of cancer models, recent studies have focused on the role of
cannabinoid receptor agonists (both CB1 and CB2) in the treatment of
estrogen receptor-negative breast cancer. This review will summarize
the anti-cancer properties of the cannabinoids, discuss their
potential mechanisms of action, as well as explore controversies
surrounding the results. Keywords: Cannabinoids; JWH-133; CB1; CB2;
MAPK
[The endocannabinoid system as a target for the development of new
drugs for cancer therapy]. [Article in Italian] Bifulco M, Di Marzo V.
Source Dipartimento di Scienze Farmaceutiche, Università di Salerno,
Istituto di Endocrinologia ed Oncologia Sperimentale del CNR,
Dipartimento di Biologia e Patologia Cellulare e Molecolare,
Università Federico II, Napoli. maubiful@unina.it Abstract Studies on
the main bioactive components of Cannabis sativa, the cannabinoids,
and particularly delta 9-tetrahydrocannabinol (THC), led to the
discovery of a new endogenous signalling system that controls several
physiological and pathological conditions: the endocannabinoid system.
This comprises the cannabinlid receptors, their endogenous
agonists--the endocannabinoids--and proteins for endocannabinoid
biosynthesis and inactivation. Recently, evidence has accumulated
indicating that stimulation of cannabinoid receptors by either THC or
the endocannabinoids influence the intracellular events controlling
the proliferation and apoptosis of numerous types of cancer cells,
thereby leading to anti-tumour effects both in vitro and in vivo. This
evidence is reviewed here and suggests that future anti-cancer therapy
might be developed from our knowledge of how the endocannabinoid
system controls the growth and metastasis of malignant cells. PMID:
12723496 [PubMed - indexed for MEDLINE]